RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Synthesis of
3 H,
13 C
2 ,
2 H
4
14 C-SCH 430765 and
35 S-SCH 500946, potent and selective inhibitors of the NPY
5 receptor.
Hesk, D., Koharski, D., McNamara, P., Royster, P., Saluja, S., Truong, V., & Voronin, K. (2018). Synthesis of
3 H,
13 C
2 ,
2 H
4
14 C-SCH 430765 and
35 S-SCH 500946, potent and selective inhibitors of the NPY
5 receptor.Journal of Labelled Compounds and Radiopharmaceuticals, 61(7), 533-539. https://doi.org/10.1002/jlcr.3617
SCH 430765 and SCH 500496 are potent and selective antagonists of the NPY5 receptor. NPY5 receptor antagonists have the potential for the treatment of obesity. [S-35]SCH 500946 was prepared for a competition binding assay which led to the identification of SCH 430765. Three distinct isotopically labelled forms of SCH 430765 were synthesized. [H-3]SCH 430765 was prepared for a preliminary absorption, distribution, metabolism and excretion data evaluation of the compound and [C-14]SCH 430765 for more definitive absorption, distribution, metabolism and excretion data work. In addition, [C-13(2),H-2(4)]SCH 430765 was prepared as an internal standard for a LC-MS bioanalytical method. The paper discusses the synthesis of 3 isotopically labelled forms of SCH 430765 and [S-35]SCH 500946.
